This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Avi Kapoor 5 months ago
Analyst ColorDowngradesPrice TargetAnalyst Ratings
Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Residential and Caesars Entertainment.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Robert Burns downgraded Cardiff Oncology Inc (NASDAQ:CRDF) from Buy to Neutral. Cardiff Oncology shares closed at $1.90 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Mitchell S. Kapoor downgraded Crescent Biopharma Inc (NASDAQ:CBIO) from Buy to Neutral. Crescent Biopharma shares closed at $ 20.65 on Monday. See how other analysts view this stock.
- Craig-Hallum analyst Anthony Stoss downgraded Corsair Gaming Inc (NASDAQ:CRSR) from Buy to Hold and announced a price target of $10. Corsair Gaming shares closed at $12.14 on Monday. See how other analysts view this stock.
- Evercore ISI Group analyst Steve Sakwa downgraded Equity Residential (NYSE:EQR) from Outperform to In-Line and maintained a price target of $70. Equity Residential shares closed at $65.45 on Monday. See how other analysts view this stock.
- Deutsche Bank analyst Carlo Santarelli downgraded Caesars Entertainment Inc (NASDAQ:CZR) from Buy to Hold and cut the price target from $35 to $31. Caesars Entertainment shares closed at $29.05 on Monday. See how other analysts view this stock.